1 / 8Hindustan Unilever Ltd | The company will acquire 100 percent of the shareholding of Zywie Ventures Private Ltd through subscription of shares of Zywie Ventures Private Limited and purchase of shares from its existing shareholders in two tranches. Additionally, the company has entered into definitive documents to acquire 19.8 percent shareholding of Nutritionalab Private Ltd for Rs 70 crore.
2 / 8One 97 Communications Ltd | The board will consider a proposal for buyback of the fully paid-up equity shares of the company.
3 / 8Sun Pharmaceutical Industries Ltd | The company issued clarification regarding the USFDA import alert at the Halol facility. The company stated that it will not revise its revenue guidance for the fiscal and will evaluate product transfers on case-to-case basis.
4 / 8Tata Consultancy Services Ltd | The company and Barclays in India have expanded their partnership to help more children with neuro-muscular disabilities become self-reliant by bringing the TCS Virtual Habilitation (VHAB) solution to Bal Kalyan Sanstha in Pune. As part of the collaboration, the company is deploying and supporting its VHAB solution and Barclays, as part of its Disability and Mental Health Network “Reach” is providing the hardware, equipment, and ongoing support.
5 / 8Max Financial Services Ltd | The company informed that it has completed the acquisition of the balance 5.17 percent stake held by Mitsui Sumitomo Insurance Company Ltd, Japan, in Max Life Insurance Company Ltd, a material subsidiary of the company.
6 / 8Spandana Sphoorty Financial Ltd | The company’s board approved and allotted 1,000 senior, secured, rated, listed, redeemable, non-convertible debentures having face value of Rs 10,00,000 each on a private placement basis for consideration of an aggregate amount of Rs 100 crores.
7 / 8Lupin Ltd | The pharma major announced the appointment of Spiro Gavaris as President US Generics business. He most recently served as President of Specialty Generics business at Mallinckrodt Pharmaceuticals and the President of US Injectables at Hikma.
8 / 8Karur Vysya Bank Ltd | The lender has hiked its benchmark rate, repo linked (EBR-R) of the bank. The revised rate stand at 9.35 percent.
